MedTrace Logo

Tissue Resistivity in Breast Cancer Patients

NCT03402997 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2019-12-12

No results posted yet for this study

Summary

The resistivity measurements will be done by introducing a needle-probe into fresh healthy, peritumoral, and tumoral ex vivo tissues.

Conditions

Interventions

DIAGNOSTIC_TEST

Resistivity measurement

To measure and compare the tissue impedance values obtained by analysing ex vivo non-neoplastic (healthy and peritumoral) and neoplastic breast tissues

Sponsors & Collaborators

  • Politecnico di Milano

    collaborator OTHER

  • Clinical Trial Unit Ente Ospedaliero Cantonale

    collaborator OTHER

  • Ente Ospedaliero Cantonale, Bellinzona

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-15
Primary Completion
2019-09-25
Completion
2019-09-25

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03402997 on ClinicalTrials.gov